CAM
BIIB icon

ClariVest Asset Management’s Biogen BIIB Stock Holding History

ClariVest Asset Management’s Portfolio BIIB Stock Details BIIB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		$457 Hold
2
– – ﹤0.01% 788
2024
Q2 		$457 Buy
+2
New +$435 ﹤0.01% 788
2023
Q4 		– Sell
-2
Closed -$1K – 886
2023
Q3 		$1K Buy
+2
New +$535 ﹤0.01% 579
2020
Q2 		– Sell
-6
Closed -$2K – 781
2020
Q1 		$2K Buy
6
+1
+20% +$303 ﹤0.01% 622
2019
Q4 		$2K Sell
5
-862
-99% -$239K ﹤0.01% 572
2019
Q3 		$202K Buy
+867
New +$202K ﹤0.01% 490
2019
Q1 		– Sell
-60,035
Closed -$18.1M – 711
2018
Q4 		$18.1M Sell
60,035
-2,671
-4% -$852K 0.39% 63
2018
Q3 		$22.2M Sell
62,706
-4,308
-6% -$1.48M 0.39% 67
2018
Q2 		$19.4M Sell
67,014
-5,114
-7% -$1.44M 0.34% 70
2018
Q1 		$19.7M Sell
72,128
-1,918
-3% -$595K 0.34% 75
2017
Q4 		$23.6M Buy
74,046
+16,046
+28% +$5.15M 0.41% 68
2017
Q3 		$18.2M Sell
58,000
-2,462
-4% -$729K 0.42% 65
2017
Q2 		$16.4M Sell
60,462
-2,170
-3% -$574K 0.4% 68
2017
Q1 		$17.1M Sell
62,632
-3,473
-5% -$982K 0.43% 67
2016
Q4 		$18.7M Buy
66,105
+21,835
+49% +$6.47M 0.5% 61
2016
Q3 		$13.9M Buy
44,270
+43,920
+12,549% +$13M 0.4% 73
2016
Q2 		$85K Hold
350
– – ﹤0.01% 535
2016
Q1 		$91K Hold
350
– – ﹤0.01% 519
2015
Q4 		$107K Buy
350
+26
+8% +$7.47K ﹤0.01% 501
2015
Q3 		$95K Buy
324
+322
+16,100% +$106K ﹤0.01% 480
2015
Q2 		$1K Hold
2
– – ﹤0.01% 561
2015
Q1 		$1K Sell
2
-188
-99% -$74.1K ﹤0.01% 556
2014
Q4 		$64K Sell
190
-2
-1% -$647 ﹤0.01% 437
2014
Q3 		$64K Buy
+192
New +$63.3K ﹤0.01% 465

Other funds holding BIIB

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $169B AUM 114.72% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

ClariVest Asset Management's BIIB Position: Q3 2024 in Review

ClariVest Asset Management held its Biogen (BIIB) position steady in Q3 2024 at 2 shares worth $457. The position accounts for ﹤0.01% of the portfolio, ranked #788.

ClariVest Asset Management first reported a position in BIIB in Q3 2014 and has held it in 24 quarters since. The position peaked at $23.6M in Q4 2017. 917 funds tracked by Wall St. Rank hold BIIB as of Q3 2024.

  • ClariVest Asset Management held 2 shares of Biogen worth $457 as of Q3 2024.
  • ClariVest Asset Management left its Biogen share count unchanged in Q3 2024.
  • Biogen made up ﹤0.01% of ClariVest Asset Management's portfolio in Q3 2024, its #788 holding.
  • ClariVest Asset Management first reported a position in Biogen in Q3 2014 and has held it in 24 quarters since.
  • ClariVest Asset Management's Biogen position peaked at $23.6M in Q4 2017.
  • 917 funds tracked by Wall St. Rank held Biogen as of Q3 2024.

Based on ClariVest Asset Management's 13F filing for Q3 2024, filed 12 Nov 2024.